Etoricoxib Induced Toxic Epidermal Necrolysis: A Case Report
1, 1, 1, 2, 1
- 1Department of Pharmacy Practice, Karavali College of Pharmacy, Vamanjoor, Mangalore, Karnataka, INDIA..
- 2Department of Dermatology, Father Muller Medical College Hospital, Mangalore, Karnataka, INDIA..
CORRESPONDENCE
Saba Farooqui
Department of Pharmacy Practice, Karavali College of Pharmacy, Vamanjoor, Mangalore, Karnataka, INDIA..
Received: 02-11-2023; Accepted: 21-02-2023.
Volume 17, Issue 1 · pp. 89-92 · 2024 · DOI: 10.5530/ijopp.17.1.15
ABSTRACT
Toxic Epidermal Necrolysis (TEN) is a rare and life-threatening skin reaction that can quickly lead to dehydration and infection. TEN is perhaps the most formidable disease encountered by dermatologists, and it remains as puzzling a disorder as it was when described by Lyell. Etoricoxib is a medication that has been associated with TEN. The ideal medical management of TEN should be multidisciplinary and requires early diagnosis and withdrawal of suspected/causative drug(s), supportive care, and specific therapy. Here we present a case of Toxic Epidermal Necrolysis due to Etoricoxib in an immune-compromised patient.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Farooqui, S., Shyma, Z., Zulekha, S., Martis, J., & V, A. V. (2024). Etoricoxib Induced Toxic Epidermal Necrolysis: A Case Report. Indian Journal of Pharmacy Practice, 17(1), 89-92. https://doi.org/10.5530/ijopp.17.1.15
Copyright and licence
© 2024 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. CC BY 4.0